Drug Profile
NGD 911
Latest Information Update: 04 Aug 2009
Price :
$50
*
At a glance
- Originator Neurogen Corporation
- Developer Neurogen Corporation; Pfizer
- Class Anxiolytics
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 23 Jan 1997 Suspended-I for Anxiety disorders in USA (PO)